BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6440937)

  • 1. [Spinocerebellar degenerations].
    Sobue I
    Nihon Naika Gakkai Zasshi; 1984 Oct; 73(10):1415-31. PubMed ID: 6440937
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute and chronic effects of thyrotropin-releasing hormone (TRH) on stabilogram in spinocerebellar degenerations.
    Yoshida M; Nakanishi T; Komatsu Y
    Tohoku J Exp Med; 1986 Mar; 148(3):327-31. PubMed ID: 3085285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinocerebellar degenerations--clinical aspects and new treatment of ataxia.
    Sobue I
    Jpn J Med; 1985 Feb; 24(1):62-7. PubMed ID: 3923240
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations.
    Sobue I; Takayanagi T; Nakanishi T; Tsubaki T; Uono M; Kinoshita M; Igata A; Miyazaki M; Yoshida M; Ando K
    J Neurol Sci; 1983 Oct; 61(2):235-48. PubMed ID: 6417282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New connection of hypothalamic hormone and the function of CNS...with special reference to relationship between TRH and ataxia (author's transl)].
    Sobue E
    Rinsho Shinkeigaku; 1977 Dec; 17(12):791-9. PubMed ID: 204434
    [No Abstract]   [Full Text] [Related]  

  • 6. Motor disabilities and effects of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration.
    Kimura I; Ohtomo H; Kogure K
    Tohoku J Exp Med; 1983 Apr; 139(4):331-7. PubMed ID: 6408760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRH and spinocerebellar degeneration.
    LeWitt PA; Ehrenkranz JR
    Lancet; 1982 Oct; 2(8305):981. PubMed ID: 6127475
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic experimentation with TRH administered intramuscularly in spinocerebellar degeneration. Double-blind cross-over study in 30 subjects].
    Filla A; De Michele G; Di Martino L; Mengano A; Iorio L; Maggio MA; Campanella G
    Riv Neurol; 1989; 59(2):83-8. PubMed ID: 2505370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRH treatment in cerebellar ataxia following a lightning stroke.
    Morocutti C; Spadaro M; Amabile G
    Ital J Neurol Sci; 1989 Oct; 10(5):531. PubMed ID: 2509400
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of thyrotropin-releasing hormone in the treatment of cerebellar ataxia.
    Takeuchi Y; Fujiwara K; Ishimura K; Shimada Y; Ochi M; Yoshioka H; Sawada T
    Pediatr Neurol; 1989; 5(2):107-10. PubMed ID: 2469426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Symptomatic analysis of cerebellar ataxia].
    Ando N
    No To Shinkei; 1995 Jan; 47(1):15-21. PubMed ID: 7669397
    [No Abstract]   [Full Text] [Related]  

  • 12. Bedside and electro-oculographic analysis of abnormal ocular movements in spinocerebellar degenerations: effects of thyrotropin-releasing hormone.
    Yamamoto H; Saito S; Sobue I
    Neurology; 1988 Jan; 38(1):110-4. PubMed ID: 3122069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration.
    Sobue I; Yamamoto H; Konagaya M; Iida M; Takayanagi T
    Lancet; 1980 Feb; 1(8165):418-9. PubMed ID: 6101863
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological treatments of cerebellar ataxia.
    Ogawa M
    Cerebellum; 2004; 3(2):107-11. PubMed ID: 15233578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ataxia in rolling mouse Nagoya and the norepinephrine system--a psychopharmacological study].
    Matsui K; Toyoshima E; Mano U; Ando K
    Yakubutsu Seishin Kodo; 1982 Dec; 2(2):77-80. PubMed ID: 6821292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of Cockayne syndrome with cerebellar ataxia improved after TRH therapy (author's transl)].
    Naito H
    Horumon To Rinsho; 1982 Mar; 30(3):261-6. PubMed ID: 6807582
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical studies of spinocerebellar degeneration].
    Sohue I
    Nihon Naika Gakkai Zasshi; 1984 Feb; 73(2):175-8. PubMed ID: 6427370
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic trial in a family with late cerebellar atrophy].
    Gracia Naya M; Pina Latorre MA
    Neurologia; 1991 May; 6(5):188-9. PubMed ID: 1908256
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of DN-1417, a synthetic thyrotropin-releasing hormone analogue, on [3H]GABA binding in the cerebellum of ataxic rats.
    Tatsuoka Y; Kato Y; Imura H
    Neurosci Lett; 1985 Jan; 53(1):63-8. PubMed ID: 2986054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on thyrotropin releasing hormone in cerebellar ataxia mutant mouse brain.
    Fukuma N; Nihei N
    Life Sci; 1986 May; 38(18):1625-31. PubMed ID: 2871469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.